Texas Bank & Trust Co Purchases New Stake in Lam Research Corporation $LRCX

Texas Bank & Trust Co acquired a new position in shares of Lam Research Corporation (NASDAQ:LRCX) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 2,970 shares of the semiconductor company’s stock, valued at approximately $289,000.

A number of other large investors also recently added to or reduced their stakes in LRCX. Brighton Jones LLC lifted its holdings in Lam Research by 1,032.4% in the fourth quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company’s stock valued at $1,025,000 after buying an additional 12,936 shares during the period. Golden State Wealth Management LLC grew its holdings in Lam Research by 18.5% during the 1st quarter. Golden State Wealth Management LLC now owns 2,249 shares of the semiconductor company’s stock worth $164,000 after acquiring an additional 351 shares during the period. Rossby Financial LCC bought a new stake in shares of Lam Research during the 1st quarter valued at $37,000. Private Trust Co. NA lifted its stake in shares of Lam Research by 18.6% in the 1st quarter. Private Trust Co. NA now owns 6,441 shares of the semiconductor company’s stock valued at $468,000 after purchasing an additional 1,010 shares during the period. Finally, OneDigital Investment Advisors LLC boosted its position in shares of Lam Research by 29.7% in the 1st quarter. OneDigital Investment Advisors LLC now owns 13,777 shares of the semiconductor company’s stock worth $1,002,000 after purchasing an additional 3,153 shares during the last quarter. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts recently commented on LRCX shares. Needham & Company LLC upped their price objective on Lam Research from $150.00 to $160.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $170.00 price target on shares of Lam Research in a research note on Thursday, October 23rd. B. Riley increased their price target on shares of Lam Research from $160.00 to $175.00 and gave the company a “buy” rating in a research report on Monday, October 20th. Wells Fargo & Company boosted their price objective on shares of Lam Research from $135.00 to $145.00 and gave the company an “equal weight” rating in a report on Thursday, October 23rd. Finally, JPMorgan Chase & Co. upped their target price on shares of Lam Research from $113.00 to $165.00 and gave the company an “overweight” rating in a research note on Thursday, October 23rd. One analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $148.54.

Insider Activity

In other news, insider Ava Harter sold 9,010 shares of the business’s stock in a transaction dated Monday, October 27th. The stock was sold at an average price of $157.47, for a total value of $1,418,804.70. Following the sale, the insider directly owned 56,786 shares in the company, valued at $8,942,091.42. The trade was a 13.69% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Vahid Vahedi sold 52,190 shares of the company’s stock in a transaction dated Monday, October 13th. The stock was sold at an average price of $138.90, for a total value of $7,249,191.00. Following the transaction, the senior vice president directly owned 251,047 shares of the company’s stock, valued at $34,870,428.30. This represents a 17.21% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.31% of the company’s stock.

Lam Research Price Performance

NASDAQ LRCX opened at $157.46 on Monday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.60 and a current ratio of 2.21. The stock has a market cap of $197.77 billion, a price-to-earnings ratio of 34.68, a PEG ratio of 1.68 and a beta of 1.84. The business has a 50 day simple moving average of $129.13 and a 200 day simple moving average of $103.49. Lam Research Corporation has a 52-week low of $56.32 and a 52-week high of $165.22.

Lam Research (NASDAQ:LRCX) last released its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The company had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.23 billion. During the same quarter in the prior year, the company earned $0.86 earnings per share. The business’s quarterly revenue was up 27.7% compared to the same quarter last year. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Analysts anticipate that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Shareholders of record on Wednesday, September 24th were issued a dividend of $0.26 per share. This is a boost from Lam Research’s previous quarterly dividend of $0.23. The ex-dividend date was Wednesday, September 24th. This represents a $1.04 dividend on an annualized basis and a yield of 0.7%. Lam Research’s dividend payout ratio is currently 22.91%.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.